Challenges and Opportunities in Australian Tobacco Control: A Study

Aug.19.2022
Challenges and Opportunities in Australian Tobacco Control: A Study
PubMed.gov study evaluates challenges and opportunities in Australian smoking control efforts, advocating for continued investment and industry intervention solutions.

PubMed.gov has released a study aiming to gain a better understanding of the challenges and opportunities for tobacco control in Australia, and accelerate progress in this field. The study aims to explore the challenges and identify priorities for policy and practice.


Method: This study involved interviewing 31 individuals in Australia who work in tobacco/nicotine-related research, policy, and practice. Interviewees included tobacco control and smoking cessation advocates, researchers, government officials, and healthcare professionals.


Result: Challenges in tobacco regulation include distraction from reforms by the proliferation of electronic cigarettes, insufficient government investment, misunderstanding of smoking cessation goals, and interference from the tobacco industry. Advocating for tobacco control to have a prominent place in political agendas, continued investment in measures, improving support for smoking cessation, and addressing industry interference are seen as important means of tackling these challenges.


Conclusion: Some challenges are believed to impede Australia's anti-smoking efforts, such as sacrificing effective control measures in favor of an excessive focus on e-cigarettes. These challenges need to be immediately addressed.


Impact on public health: Strengthening efforts to control smoking remains a primary means of preventing death. Developing evidence-based national strategies to quit smoking and taking measures to protect tobacco control efforts from those with vested interests are crucial in reducing smoking prevalence.


Keywords: electronic cigarettes; industry interference; smoking; tobacco control.


The year 2022.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Yekaterinburg shuts down illegal e-cigarette oil factory; Russia plans to ban e-cigarette sales
Yekaterinburg shuts down illegal e-cigarette oil factory; Russia plans to ban e-cigarette sales
An illegal e-cigarette oil factory was shut down in Yekaterinburg, Russia. The illegal e-cigarette oil was produced under unsanitary conditions, with falsified addresses and production dates on product labels. Some of the employees were hearing-impaired. The Russian government plans a complete ban on e-cigarette sales, which has received support from the president.
Sep.30 by 2FIRSTS.ai
InterTabac 2025 Insights|Altria Brings Two Nicotine Pouch Brands—On! and FUMi to InterTabac
InterTabac 2025 Insights|Altria Brings Two Nicotine Pouch Brands—On! and FUMi to InterTabac
2Firsts’ on-site reporting at InterTabac 2025 in Dortmund, Germany, found that Altria exhibited two nicotine pouch brands: On! and FUMi.
Sep.19 by 2FIRSTS.ai
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
US FDA meeting minutes: Under Trump, a new pilot eases nicotine pouch rules—cuts product-specific research (uses generic data), shortens reviews, boosts communication. It’s the FDA’s first clear softer stance on smoking alternatives. The pilot may benefit Philip Morris (Zyn), Altria (On!), BAT (Velo) but sparks debate: FDA says pouches are low-risk (no youth surge), while ex-officials/academics cite missing research (hurts health checks, risks hidden youth use). Firms note costly research remain
Sep.19 by 2FIRSTS.ai
The New South Wales lower house of parliament in Australia passed a bill that could see up to seven years in prison for selling illegal tobacco
The New South Wales lower house of parliament in Australia passed a bill that could see up to seven years in prison for selling illegal tobacco
The NSW Lower House passed a bill cracking down on illegal tobacco. It allows health authorities to shut down non-compliant shops for up to 90 days and sets penalties of up to 7 years in prison or A$1.5 million in fines for large-scale sales. The opposition-led bill, backed by the government, targets organized crime funding and enhances public safety.
Sep.12 by 2FIRSTS.ai
Chile MoH Launches “Humos Letales 3: Comeback” — Spotlight on Vaping Harms, Headline Message “Vapear te mata (Vaping kills)”
Chile MoH Launches “Humos Letales 3: Comeback” — Spotlight on Vaping Harms, Headline Message “Vapear te mata (Vaping kills)”
Chile’s Ministry of Health (MINSAL), together with students from Providencia’s Carmela Carvajal High School, unveiled the third season of the anti-tobacco campaign Humos Letales (“Deadly Smokes”), titled “Comeback.” The new wave squarely targets youth vaping, using direct language and a punchy video to boost risk perception. Government data cited from SENDA (2023) show 34.7% of students (8th grade–12th grade) have ever used e-cigarettes and 8.6% used them monthly. Families, schools, and communit
Sep.11 by 2FIRSTS.ai
Heno Biotech Releases 2024 ESG Report at Inter Tabac, Setting a New Global Benchmark for the Nicotine Industry Through Green Development and Compliance Governance
Heno Biotech Releases 2024 ESG Report at Inter Tabac, Setting a New Global Benchmark for the Nicotine Industry Through Green Development and Compliance Governance
At InterTabac, the world’s largest tobacco industry exhibition in Dortmund, Germany, Heno Biotech released its 2024 Environmental, Social, and Governance (ESG) Report. As a leading enterprise in China’s natural nicotine sector, Heno presented its third consecutive annual ESG disclosure, highlighting achievements in green development, compliance governance, and social responsibility, setting a new benchmark for sustainable growth in the industry.
Sep.18